Literature DB >> 28441669

Keep them breathing: Cystic fibrosis pathophysiology, diagnosis, and treatment.

Sheena D Brown1, Rachel White, Phil Tobin.   

Abstract

Cystic fibrosis (CF) affects more than 30,000 people in the United States and 80,000 people worldwide. This life-threatening genetic disorder causes a buildup of thick, viscous mucus secretions in various organ systems, most commonly the gastrointestinal, pulmonary, and genitourinary systems. This article reviews the clinical manifestations, diagnosis, and monitoring of patients with CF as well as guidelines for management and emerging pharmacologic treatments.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28441669     DOI: 10.1097/01.JAA.0000515540.36581.92

Source DB:  PubMed          Journal:  JAAPA        ISSN: 0893-7400


  19 in total

Review 1.  The Role of HMGB1, a Nuclear Damage-Associated Molecular Pattern Molecule, in the Pathogenesis of Lung Diseases.

Authors:  Mao Wang; Alex Gauthier; LeeAnne Daley; Katelyn Dial; Jiaqi Wu; Joanna Woo; Mosi Lin; Charles Ashby; Lin L Mantell
Journal:  Antioxid Redox Signal       Date:  2019-07-11       Impact factor: 8.401

2.  Using A Work System Framework to Investigate Pharmacists' Roles in Cystic Fibrosis Management.

Authors:  Olufunmilola Abraham; Megan Buechel; Sommer Gay; Lisa Szela; Catherine A Decker; Andrew T Braun
Journal:  J Pediatr Pharmacol Ther       Date:  2022-03-21

3.  Identification of Key Factors for Anoxic Survival of B. cenocepacia H111.

Authors:  Sarah Paszti; Alessandra Vitale; Yilei Liu; Rubina Braunwalder; Ratchara Kalawong; Olivier Biner; Gabriella Pessi; Leo Eberl
Journal:  Int J Mol Sci       Date:  2022-04-20       Impact factor: 6.208

Review 4.  Standard (head-down tilt) versus modified (without head-down tilt) postural drainage in infants and young children with cystic fibrosis.

Authors:  Diana A Freitas; Gabriela Ss Chaves; Thayla A Santino; Cibele Td Ribeiro; Fernando Al Dias; Ricardo O Guerra; Karla Mpp Mendonça
Journal:  Cochrane Database Syst Rev       Date:  2018-03-09

5.  Role of inhaled antibiotics in children and adolescents with cystic fibrosis: Experience from the tertiary care center.

Authors:  Danish Abdul Aziz; Aiza Abbas; Anusha Alam; Namrah Aziz
Journal:  Lung India       Date:  2022 May-Jun

6.  Chemically modified hCFTR mRNAs recuperate lung function in a mouse model of cystic fibrosis.

Authors:  A K M Ashiqul Haque; Alexander Dewerth; Justin S Antony; Joachim Riethmüller; Georg R Schweizer; Petra Weinmann; Ngadhnjim Latifi; Hanzey Yasar; Nicoletta Pedemonte; Elvira Sondo; Brian Weidensee; Anjali Ralhan; Julie Laval; Patrick Schlegel; Christian Seitz; Brigitta Loretz; Claus-Michael Lehr; Rupert Handgretinger; Michael S D Kormann
Journal:  Sci Rep       Date:  2018-11-13       Impact factor: 4.379

Review 7.  Alpha-1 Antitrypsin-A Target for MicroRNA-Based Therapeutic Development for Cystic Fibrosis.

Authors:  Alison M D Hunt; Arlene M A Glasgow; Hilary Humphreys; Catherine M Greene
Journal:  Int J Mol Sci       Date:  2020-01-28       Impact factor: 5.923

8.  Cystic fibrosis revisited.

Authors:  H Kulkarni; S Kansra; S Karande
Journal:  J Postgrad Med       Date:  2019 Oct-Dec       Impact factor: 1.476

Review 9.  Personalized or Precision Medicine? The Example of Cystic Fibrosis.

Authors:  Fernando A L Marson; Carmen S Bertuzzo; José D Ribeiro
Journal:  Front Pharmacol       Date:  2017-06-20       Impact factor: 5.810

Review 10.  Transcriptomic and Proteostasis Networks of CFTR and the Development of Small Molecule Modulators for the Treatment of Cystic Fibrosis Lung Disease.

Authors:  Matthew D Strub; Paul B McCray
Journal:  Genes (Basel)       Date:  2020-05-13       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.